These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20156115)

  • 41. Tamoxifen, antidepressants, and CYP2D6: the conundrum continues.
    Holzman D
    J Natl Cancer Inst; 2009 Oct; 101(20):1370-1. PubMed ID: 19797723
    [No Abstract]   [Full Text] [Related]  

  • 42. CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
    Yazdi MF; Rafieian S; Gholi-Nataj M; Sheikhha MH; Nazari T; Neamatzadeh H
    Asian Pac J Cancer Prev; 2015; 16(15):6783-7. PubMed ID: 26434912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
    Hamer AM; Hartung DM; Haxby DG; Ketchum KL; Pollack DA
    J Manag Care Pharm; 2006; 12(6):449-56. PubMed ID: 16925452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.
    Regan MM; Leyland-Jones B; Bouzyk M; Pagani O; Tang W; Kammler R; Dell'orto P; Biasi MO; Thürlimann B; Lyng MB; Ditzel HJ; Neven P; Debled M; Maibach R; Price KN; Gelber RD; Coates AS; Goldhirsch A; Rae JM; Viale G;
    J Natl Cancer Inst; 2012 Mar; 104(6):441-51. PubMed ID: 22395644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen.
    Siegelmann-Danieli N; Kurnik D; Lomnicky Y; Vesterman-Landes J; Katzir I; Bialik M; Loebstein R
    Breast Cancer Res Treat; 2011 Jan; 125(2):505-10. PubMed ID: 20593233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
    Nakamura Y; Ratain MJ; Cox NJ; McLeod HL; Kroetz DL; Flockhart DA
    J Natl Cancer Inst; 2012 Aug; 104(16):1264; author reply 1266-8. PubMed ID: 22851270
    [No Abstract]   [Full Text] [Related]  

  • 49. Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
    Stanton V
    J Natl Cancer Inst; 2012 Aug; 104(16):1265-6; author reply 1266-8. PubMed ID: 22851267
    [No Abstract]   [Full Text] [Related]  

  • 50. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
    Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
    J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
    Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM
    J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors.
    Radmacher MD; Simon R
    J Natl Cancer Inst; 2000 Jan; 92(1):48-53. PubMed ID: 10620633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antidepressants and tamoxifen. Drug interactions may increase risk of cancer recurrence or death.
    Harv Ment Health Lett; 2010 Jun; 26(12):6-7. PubMed ID: 20669529
    [No Abstract]   [Full Text] [Related]  

  • 54. Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.
    Ahern TP; Christensen M; Cronin-Fenton DP; Lunetta KL; Søiland H; Gjerde J; Garne JP; Rosenberg CL; Silliman RA; Sørensen HT; Lash TL; Hamilton-Dutoit S
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1937-43. PubMed ID: 21750172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of antidepressants and breast cancer recurrence.
    Baker H
    Lancet Oncol; 2016 Jan; 17(1):e11. PubMed ID: 26687592
    [No Abstract]   [Full Text] [Related]  

  • 57. CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: lessons learned.
    Kelly CM; Pritchard KI
    J Natl Cancer Inst; 2012 Mar; 104(6):427-8. PubMed ID: 22395645
    [No Abstract]   [Full Text] [Related]  

  • 58. Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.
    Collin LJ; Cronin-Fenton DP; Ahern TP; Christiansen PM; Damkier P; Ejlertsen B; Hamilton-Dutoit S; Kjærsgaard A; Silliman RA; Sørensen HT; Lash TL
    BMJ Open; 2018 Aug; 8(7):e021805. PubMed ID: 30068618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Citalopram in pregnancy and lactation.
    Heikkinen T; Ekblad U; Kero P; Ekblad S; Laine K
    Clin Pharmacol Ther; 2002 Aug; 72(2):184-91. PubMed ID: 12189365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Do antidepressants reduce the effectiveness of tamoxifen?
    Breitbart W
    Psychooncology; 2011 Jan; 20(1):1-4. PubMed ID: 21182159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.